Ciammaruconi Andrea, Di Spirito Maria, Pascolini Chiara, Molinari Filippo, Rozov Orr, Cavalli Marzia, Campoli Giulia, Totaro Nathalie, Recchia Elisa, Chimienti Silvia, Monte Anella, Spagnolo Ferdinando, Lista Florigio, D'Amelio Raffaele, Fillo Silvia
Defense Institute for Biomedical Sciences, 00184 Rome, Italy.
Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, 00185 Rome, Italy.
Biomedicines. 2025 Oct 20;13(10):2555. doi: 10.3390/biomedicines13102555.
, the causative agent of plague, is arguably the most devastating pathogen in human history. Paleogenomic studies indicate its presence as early as the Neolithic era. It evolved from , with divergence estimates ranging from 1500 to 20,000 years ago, most often placed around 5000 years ago. Its natural reservoirs are wild mammals, particularly rodents, with fleas serving as vectors, while humans are incidental hosts. Over time, has acquired multiple virulence factors that disrupt immune responses and can lead to rapid, often fatal disease. Because the bacterium is maintained in wildlife cycles and can spill over to domestic animals, eradication is difficult, if not impossible. Nevertheless, mitigation is achievable using a One Health approach integrating human health, animal health, and the health of the environment. Neither vaccines nor monoclonal antibodies are currently licensed in most Western countries, thus, antibiotics remain the mainstay of therapy. Timely administration, ideally within 24 h of symptom onset, is critical, particularly in pneumonic forms. Phage therapy is under investigation as a potential treatment. Though often neglected in high-income settings, plague remains endemic in several regions, with the highest burden reported in Madagascar and the Democratic Republic of the Congo.